Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Published Date: 24 Jan 2025

Median PFS in GEP-NETs increased from 11.5 to 29.7 with addition of lanreotide to everolimus

Read Full News

Latest News

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Cognitive Therapy Boosts Brain Function in Schizophrenia

Structured cognitive remediation therapy helps boost brain activity, working memory, and quality of life and reduce severity of symptoms in patients with schizophrenia, a trial shows.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Latest News

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

(This Aug 27 story has been republished, with no changes to text.)

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Structured cognitive remediation therapy helps boost brain activity, working memory, and quality of life and reduce severity of symptoms in patients with schizophrenia, a trial shows.

News All Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Half of procedures occurred in settings not supported by guidelines

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Health news and commentary gathered by MedPage Today staff

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

News, features, and commentary about cancer-related issues

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

Testing could give doctors an early start on life-preserving cancer treatments

SBRT Misses the Mark in Prostate Cancer Trial

No improvement over intensity-modulated RT in urinary symptoms after 2 years, DFS after 3 years

What Caused This Young Man's Bladder Cancer

Occupational exposure, family history make tempting hypotheses

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Soared past 90% in VA system for low-risk disease, to 61% for favorable intermediate-risk disease

Melanoma Patient on Immunotherapy Develops Severe Dermatitis

Clinicians faced with presumed dermatologic AEs urged to consider all differentials

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

News, features, and commentary about cancer-related issues

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Assisted Dying Under Scrutiny From Medscape's Readers

Participate and win cash vouchers

Get updates on the latest events happening around the world

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Latest News

‘Modest’ Differences in OAT Should Not Obscure Benefits

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

Alzheimer's Blood Test Gets FDA Clearance

Less Seniors Taking Inappropriate Cognitive Meds

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

Cognitive Therapy Boosts Brain Function in Schizophrenia

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Latest News

News All Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

SBRT Misses the Mark in Prostate Cancer Trial

What Caused This Young Man's Bladder Cancer

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Melanoma Patient on Immunotherapy Develops Severe Dermatitis

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

US Mental Health Treatment Rates Rise But Gaps Persist

Cognitive Bias Modification App Fosters Alcohol Avoidance

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Recommended News For You

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

Study: For predicting breast cancer, AI performs better than traditional risk models.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

Racial differences seen in epigenetic age acceleration in childhood cancer survivors